AAAAAA

   
Results: 1-15 |
Results: 15
Single or double mutational alterations of GyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli
Authors: Bachoual, R Ouabdesselam, S Mory, F Lascols, C Soussy, CJ Tankovic, J
Citation: R. Bachoual et al., Single or double mutational alterations of GyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli, MICROB DR R, 7(3), 2001, pp. 257-261
Clarithromycin resistance of Helicobacter pylori has a major impact on theefficacy of the omeprazole-amoxicillin-clarithromycin therapy
Authors: Tankovic, J Lamarque, D Lascols, C Soussy, CJ Delchier, JC
Citation: J. Tankovic et al., Clarithromycin resistance of Helicobacter pylori has a major impact on theefficacy of the omeprazole-amoxicillin-clarithromycin therapy, PATH BIOL, 49(7), 2001, pp. 528-533
Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin
Authors: Lascols, C Bryskier, A Soussy, CJ Tankovic, J
Citation: C. Lascols et al., Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin, J ANTIMICRO, 48(5), 2001, pp. 738-740
Impact of Helicobacter pylori resistance to clarithromycin on the efficacyof the omeprazole-amoxcillin-clarithromycin therapy
Authors: Tankovic, J Lamarque, D Lascols, C Soussy, CJ Delchier, JC
Citation: J. Tankovic et al., Impact of Helicobacter pylori resistance to clarithromycin on the efficacyof the omeprazole-amoxcillin-clarithromycin therapy, ALIM PHARM, 15(5), 2001, pp. 707-713
Antibiotic susceptibility of Escherichia coil strains isolated in 1998 and1999: results of a French multicenter study.
Authors: Soussy, CJ Cavallo, JD Courcol, R Drugeon, H Fabre, R Jarlier, V Lascols, C Leclercq, R N'Guyen, J Roussel-Delvallez, M Sirot, J Derriennic-Cohen-Bacrie, M Pecking, M De Bels, F
Citation: Cj. Soussy et al., Antibiotic susceptibility of Escherichia coil strains isolated in 1998 and1999: results of a French multicenter study., MED MAL INF, 30(10), 2000, pp. 650-656
Antibiogram Committee of the French Society for Microbiology - 1999 statement
Authors: Soussy, CJ Acar, J Carret, G Cavallo, JD Chardon, H Choutet, P Courvalin, P Dabernat, H Drugeon, H Dubreuil, L Goldstein, F Jarlier, V Leclercq, R Nicolas-Chanoine, MH Philippon, A Rouveix, B Sirot, J Soussy, CJ
Citation: Cj. Soussy et al., Antibiogram Committee of the French Society for Microbiology - 1999 statement, MED MAL INF, 30(1), 2000, pp. 11-42
Antibiogram Commitee of the French Society of Microbiology. 2000-2001 Statement
Authors: Soussy, CJ Carret, G Cavallo, JD Chardon, H Chidiac, C Choutet, P Courvalin, P Dabernat, H Drugeon, H Dubreuil, L Goldstein, F Jarlier, V Leclercq, R Nicolas-Chanoine, MH Philippon, A Quentin, C Rouveix, B Sirot, J
Citation: Cj. Soussy et al., Antibiogram Commitee of the French Society of Microbiology. 2000-2001 Statement, PATH BIOL, 48(9), 2000, pp. 832-871
Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation
Authors: Thuong, M Shortgen, F Zazempa, V Girou, E Soussy, CJ Brun-Buisson, C
Citation: M. Thuong et al., Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation, J ANTIMICRO, 46(3), 2000, pp. 501-508
Methicillin-resistant Staphylococcus aureus: risk factors for high incidence.
Authors: Aubry-Damon, H Soussy, CJ
Citation: H. Aubry-damon et Cj. Soussy, Methicillin-resistant Staphylococcus aureus: risk factors for high incidence., REV MED IN, 21(4), 2000, pp. 344-352
Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin
Authors: Bachoual, R Dubreuil, L Soussy, CJ Tankovic, J
Citation: R. Bachoual et al., Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin, ANTIM AG CH, 44(7), 2000, pp. 1842-1845
Frequent association between alteration of the rdxA gene and metronidazoleresistance in French and North African isolates of Helicobacter pylori
Authors: Tankovic, J Lamarque, D Delchier, JC Soussy, CJ Labigne, A Jenks, PJ
Citation: J. Tankovic et al., Frequent association between alteration of the rdxA gene and metronidazoleresistance in French and North African isolates of Helicobacter pylori, ANTIM AG CH, 44(3), 2000, pp. 608-613
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR (vol 165, pg 369, 1998)
Authors: Sevin, E Lamarque, D Delchier, JC Soussy, CJ Tankovic, J
Citation: E. Sevin et al., Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR (vol 165, pg 369, 1998), FEMS MICROB, 173(1), 1999, pp. 275-275
In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic Gram-negative bacilli and Enterococcus faecalis
Authors: Tankovic, J Bachoual, R Ouabdesselam, S Boudjadja, A Soussy, CJ
Citation: J. Tankovic et al., In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic Gram-negative bacilli and Enterococcus faecalis, J ANTIMICRO, 43, 1999, pp. 19-23
Low HCV replication levels in end-stage hepatitis C virus-related liver disease
Authors: Duvoux, C Pawlotsky, JM Bastie, A Cherqui, D Soussy, CJ Dhumeaux, D
Citation: C. Duvoux et al., Low HCV replication levels in end-stage hepatitis C virus-related liver disease, J HEPATOL, 31(4), 1999, pp. 593-597
Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli
Authors: Bachoual, R Tankovic, J Soussy, CJ
Citation: R. Bachoual et al., Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli, MICROB DR R, 4(4), 1998, pp. 271-276
Risultati: 1-15 |